14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.814 1 day ( 0 % )
Last Price $34.01 -0.85 %
High/ Low $33.91 - $34.44 1.24%
Chg 7 Days -0.235 % $34.09 $34.01
Chg 30 Days -2.41 % $34.85 $34.01
Chg 12 mos 26.01 % $26.99 $34.01
Trend - 3 mos -11.10 % Width: 8.97 %
Trend - 12 mos 65.43 % Width: 84.62 %
Pred. range - 3 mos $29.50 - $32.14 -13.27 % - -5.49 %
Pred. range - 12 mos $38.22 - $70.56 12.38 % - 107.47 %
Short MA avg 3 mos Buy Apr 30, 2024 - 3 days
Long MA avg 3 mos Sell Feb 27, 2024 - 47 days
Short/Long MA avg 3 mos Sell Mar 05, 2024 - 42 days
Short MA avg 12 mos Sell Apr 12, 2024 - 15 days
Long MA avg 12 mos Sell Apr 22, 2024 - 9 days
Short/Long MA avg 12 mos Sell Apr 26, 2024 - 5 days
Pivot Short Sell Feb 27, 2024 - 47 days
Bollinger Buy Apr 25, 2024 - 6 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Inhibrx Inc

Inhibrx Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcinoma; INBRX-105, a tetravalent conditional agonist of programmed death-ligand 1 and a conditional agonis... INBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT